Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05796453 · ClinicalTrials.gov registry record · NA
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
A NA study of Presbyopia and Astigmatism, sponsored by Alcon Research.
- Active
- Registry status
- NA
- Development phase
- 470
- Enrollment target
- 7
- Study locations
NCT05796453 is a NA study of Presbyopia and Astigmatism that is active but no longer recruiting, run by Alcon Research. The registered enrollment target is 470 participants, above the 258-participant average among 38 other Presbyopia trials with a reported enrollment target (82% higher). The trial reports 7 study locations across 7 states.
The verdict
NCT05796453, a NA study of Presbyopia and Astigmatism, is active but no longer recruiting, sponsored by Alcon Research.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 470 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.
Conditions Studied
Interventions
- DEVICE Clareon Vivity IOL - Non Toric
- DEVICE Clareon Vivity IOL - Toric
- DEVICE Clareon PanOptix Trifocal IOL - Non Toric
- DEVICE Clareon PanOptix Trifocal IOL - Toric
Study Locations (7)
California
- Wolstan & Goldberg Eye Associates - Torrance
Florida
- Levenson Eye Associates - Jacksonville
New York
- Eye Surgeons of CNY - Liverpool
Oklahoma
- Tulsa Ophthalmology - Tulsa
Texas
- Chu Eye Institute - Fort Worth
Utah
- The Eye Institute of Utah - Salt Lake City
Other
- Centro Oftalmologico Metropolitano - San Juan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 470 participants |
| Start Date | 2023-09-19 |
| Est. Completion | 2028-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05796453
The ClinicalTrials.gov registry entry for NCT05796453 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 470 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 258-participant average among 38 other Presbyopia trials with a reported enrollment target (82% higher). The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Presbyopia appearing as the primary indexed condition, and to 4 interventions - of which Clareon Vivity IOL - Non Toric is the first listed.
NCT05796453 reports 7 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, New York.
Frequently Asked Questions
What is clinical trial NCT05796453 about?
NCT05796453 is a clinical study titled "Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix". The purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.
What is the current status of trial NCT05796453?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 470 participants. The study started on 2023-09-19. Estimated completion is 2028-06.
What conditions does trial NCT05796453 study?
This clinical trial studies the following conditions: Presbyopia, Astigmatism, Aphakia.
What interventions are being tested in trial NCT05796453?
The interventions under investigation include: Clareon Vivity IOL - Non Toric (DEVICE), Clareon Vivity IOL - Toric (DEVICE), Clareon PanOptix Trifocal IOL - Non Toric (DEVICE), Clareon PanOptix Trifocal IOL - Toric (DEVICE).
Who is sponsoring clinical trial NCT05796453?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05796453 being conducted?
This trial has 7 study locations across California, Florida, New York, Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
-
A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add
RECRUITING · NA
-
Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Clinical Evaluation of a Small Aperture Extended Depth of Focus Intraocular Lens
COMPLETED · NA
-
A Dispensing Clinical Trial of Comfilcon A Extended Range Multifocal Lenses
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.